Authors
Latest:
Q&A: The Role of Metabolomics in the Diagnosis of Psoriatic ArthritisIn this Q&A, Vinod Chandran, MBBS, MD, DM, PhD, discussed a method to analyze biomarkers that may differentiate patients with psoriasis and psoriatic arthritis.
Latest:
Overview of Neovascular Age-Related Macular Degeneration and Diabetic Macular EdemaSteven D. Schwartz, MD, reviews challenges and unmet needs in treatment of patients with neovascular AMD and DME.
Latest:
Tips for Managing Generalized Pustular Psoriasis (GPP)Dermatologists Drs Tina Bhutani and Scott Boswell and patient Kanya Oul share resources and tools available to cope with generalized pustular psoriasis (GPP).
Latest:
Heart Education: Knowledge Saves Your LifeA longtime clinician writes on the signs and risks of fatal heart attack events, including the Widowmaker.
Latest:
Emerging Agents in Psychedelic Therapy for Treatment Resistant DepressionWilliam M. Sauve, MD, reviews the landscape of delivery mechanisms for ketamine agents, including intravenous, sublingual, and intramuscular.
Latest:
Challenges With Step Therapy Protocol in Treating Rheumatoid ArthritisIn this MEDcast episode, Drs Soloman, Sharobeem, Boone and Feldman discuss the use of step therapy in rheumatoid arthritis, how step therapy was intended to be used, how it is actually used, and challenges and solutions to its use.
Latest:
Atopic Dermatitis: An Evolving Treatment LandscapeClosing out its discussion on atopic dermatitis, the panel considers best practices and unmet needs in the treatment landscape.
Latest:
Sickle Cell Disease: Unmet Needs and Future Directions in CareConcluding their discussion on sickle cell disease management, expert panelists share key unmet needs and hopes for the future.
Latest:
Mavacamten in oHCM: Navigating the REMS Program for Safe, Optimal OutcomesAnjali Tiku Owens, MD, examines mavacamten, the pioneering cardio myosin inhibitor (CMI) approved for the treatment of obstructive hypertrophic cardiomyopathy (oHCM), which is exclusively accessible through the restricted Risk Evaluation and Mitigation Strategy (REMS) program; the KOL delves into the objectives of this program and how it strives to enhance medication safety and optimize patient outcomes.
Latest:
Appropriate Guidance for CRC Screening Age, Role of Advocacy OrganizationsIn part 5 of our 5-part discussion, experts discuss their perspective on appropriate guidance for screening age and the future of CRC advocacy.
Latest:
Final Thoughts on Management of ADHDADHD experts share their final thoughts on the treatment and management of ADHD.
Latest:
Final Thoughts: Awareness and Communication in DiabetesThought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers.
Latest:
Unmet Needs in Sickle Cell Disease ManagementStrategies to avoid complications of sickle cell disease and ensure non-dependency on opioids when treating patients for pain as a result of the disease.
Latest:
Future Directions in the Treatment of Opioid-Induced ConstipationA panel of experts discuss their key takeaways and the future of treating opioid-induced constipation.
Latest:
Advancing the State of Precision Medicine In Rheumatoid ArthritisExpert rheumatologists discuss precision medicine in rheumatoid arthritis. In particular, they discuss available data and the value of various tools in guiding treatment selection in routine clinical practice.
Latest:
The Role of Screening, Addressing Cognitive Impairment in Heart Failure ManagementEiran Gorodeski, MD, MPH, Parag Goyal, MD, MSc, and James Fang, MD, discuss the HFSA's recent scientific statement on the prevalence and impact of cognitive impairment on the management of heart failure.
Latest:
Emerging Agents in The Treatment of GoutIn this discussion, experts focus on emerging treatment options for gout and share tips for monitoring and managing gout in patients with comorbid conditions.
Latest:
The Future of Heart Failure TherapyAnuradha Lala-Trindade, MD, shares developments in the pipeline for heart failure therapy, as well as clinical pearls for health care providers managing patients with heart failure.
Latest:
Beyond Skin Deep: Validating and Transforming SD Patient CareDermatologists end their discussion on seborrheic dermatitis (SD), highlighting key takeaways for patients and clinicians on managing this condition.
Latest:
Role of Advocacy, Patient Voice in Hepatitis BIn this segment of our 6-part discussion on updates and unmet needs within the management of hepatitis B virus focuses on the role of advocacy and patient voice in HBV management.
Latest:
Practical Takeaways and Future Directions in DME and AMDRetina specialists share advice and practice pearls regarding the management of DME and neovascular AMD, including counseling patients about the importance of healthy lifestyles.
Latest:
Addressing Stigma to Improve Outcomes in Alcohol-Related Liver DiseaseThe second segment of a special report stresses the importance of cross-specialty collaboration with hepatology and psychiatry when treating alcohol-related liver disease.
Latest:
Resources for Patients and Providers on Adalimumab BiosimilarsExpert providers in inflammatory diseases provide additional resources on biosimilars and adalimumab biosimilar for patients and providers.
Latest:
Using DOACs in People with Chronic Kidney Disease, with Kim Zuber, PA-C, and Jane Davis, DNPKim Zuber, PA-C, and Jane Davis, DNP, offer insight into the use of DOACs in people with atrial fibrillation and chronic kidney disease.
Latest:
Diabetes, GLP-1, and Lipid ReductionMichael Blaha, MD, highlights the potential of GLP-1 agonists in lowering LDL cholesterol, triglycerides, and body weight in patients with diabetes, presenting them as an additional option for reducing cardiovascular risk in this patient population.
Latest:
Don't Miss a Beat: Semaglutide and the Future of Kidney Disease, with Brendon Neuen, MBBS, PhDBrendon Neuen, MBBS, PhD, joins the podcast to discuss the latest updates in nephrology, including the landmark FLOW trial.
Latest:
Practice Pearls for the Management of SCDA panel of experts in hematology discuss the future directions for sickle cell disease and share practice pearls for disease management.
